Search ESTA
ESTABLISHMENT LABS HOLDINGS INC.
Nasdaq · CIK 1688757
Last close64.06
Daily change+1.02 (1.62%)
10 Years gain+158.83%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ESTA · STANDARD
SIC 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Fiscal year end 1231
Fundamental
51.3Momentum
100.0Acceleration
96.7Confidence
91.0Annual Revenue9
Quarterly Revenue28
Annual CFO9
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth15.5 / 25
Quality19.1 / 25
Capital Efficiency4.7 / 20
Balance Sheet8.0 / 15
Shareholder Economics1.4 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 4.5216 percentage points.
Operating leverageOperating margin improved by 17.1853 percentage points.
ROIC expansionROIC improved by 8.3434 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM42.74%OK
Revenue CAGR 3Y9.29%OK
Gross Margin70.11%OK
Operating Margin-12.44%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-9.7%OK
Incremental Operating Margin 3Y0.79%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y2.19%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $211.08M | $146.31M | -$39.01M | -$50.89M | -$56.94M | 69.32% | -18.48% | -26.98% | -38.95% | 29.62M |
| 2025 FY Dec 31, 2024 | $166.03M | $109.53M | -$49.99M | -$58.52M | -$64.63M | 65.97% | -30.11% | -38.93% | -60.83% | 28.16M |
| 2025 FY Dec 31, 2023 | $165.15M | $106.98M | -$65.03M | -$88.51M | -$96.42M | 64.78% | -39.37% | -58.38% | -38.33% | 25.6M |
| 2024 FY Dec 31, 2022 | $161.70M | $106.60M | -$39.66M | -$52.17M | -$55.02M | 65.92% | -24.53% | -34.02% | -63.78% | 24.46M |
| 2023 FY Dec 31, 2021 | $126.68M | $85.40M | -$25.14M | -$27.53M | -$29.96M | 67.42% | -19.85% | -23.65% | n/a | 23.97M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $232.50M | sum latest 4 fiscal quarters Revenue | OK | 0001688757-26-000050, 0001688757-25-000065 |
| Revenue Growth TTM | 42.74% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001688757-26-000050, 0001688757-25-000065 |
| Revenue CAGR 3Y | 9.29% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001688757-26-000022 |
| Revenue CAGR 5Y | 20.04% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001688757-26-000022 |
| Gross Profit CAGR 3Y | 11.13% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001688757-26-000022 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001688757-26-000050, 0001688757-25-000065 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 70.11% | Gross Profit / Revenue | OK | 0001688757-26-000050, 0001688757-25-000065 |
| Operating Margin | -12.44% | Operating Income / Revenue | OK | 0001688757-26-000050, 0001688757-25-000065 |
| ROIC | -9.7% | NOPAT / Average Invested Capital | OK | 0001688757-26-000050, 0001688757-25-000065 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001688757-26-000050 |
| Current Ratio | 3.84x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.27x | (Cash + Short-term Investments) / Total Debt | OK | 0001688757-26-000050 |
| Revenue per Diluted Share | $7.72 | Revenue / Diluted Shares | OK | 0001688757-26-000050, 0001688757-25-000065 |